Used for diagnosing gastroesophageal reflux, the devices may not attach or detach correctly, potentially causing serious ...

Medtronic is one of the largest pure-play medical device stocks you can buy. The stock is yielding a historically attractive ...

Medtronic (NYSE:MDT) experienced a price increase of 7% over the last quarter, which may have been influenced by notable ...

The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

Medtronic PLC closed 7.97% below its 52-week high of $96.25, which the company achieved on March 10th.

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

Goldman Sachs analyst David Roman reiterated a Sell rating on Medtronic today and set a price target of $78.00. The company’s shares closed today at $89.92. Take advantage of TipRanks Premium at 50% ...

Nearly 70 years into her history, Barbie is still undergoing regular makeovers. | Nearly 70 years into her history, Barbie is ...

However, in the postreform healthcare world where there are higher hurdles for securing reimbursement for next-generation technology, Medtronic has had to move in the direction of introducing ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...